Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Cell Death & Disease|March 31, 2017
MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2Alip Ghosh, Debanjali Dasgupta, Amit Ghosh, et al.
Frontiers in Immunology|December 26, 2023
Influence of polymorphisms in TNF-α and IL1β on susceptibility to alcohol induced liver diseases and therapeutic potential of miR-124-3p impeding TNF-α/IL1β mediated multi-cellular signaling in liver microenvironmentDebanjali Dasgupta, Suchandrima Ghosh, Indrashish Dey, et al.
Plos One|July 18, 2014
Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patientsSomenath Datta, Shrabasti Roychoudhury, Alip Ghosh, et al.
Plos One|October 27, 2017
Etiology and mode of presentation of chronic liver diseases in India: A multi centric studyPartha S Mukherjee, Sreenivas Vishnubhatla, Deepak N Amarapurkar, et al.
International Journal of Cardiology|October 11, 2016
Hepatic steatosis is associated with cardiometabolic risk in a rural Indian population: A prospective cohort studyAnamitra Barik, Ravi V Shah, Aferdita Spahillari, et al.
Plos One|August 11, 2021
Reciprocal interplay between asporin and decorin: Implications in gastric cancer prognosisDipjit Basak, Zarqua Jamal, Arnab Ghosh, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter StudySubrat K Acharya, V Sreenivas, Siddharth Datta Gupta, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 16, 2016
Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypesSamir R Shah, P N Rao, Shiv K Sarin, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialHenry L Y Chan, Scott Fung, Wai Kay Seto, et al.
Pageof 14